ISPE Facility of the Year Awards Program Enters Second Decade

With 10 years under its belt, the popular global awards program continues its focus on recognizing innovation in manufacturing facilities serving the regulated healthcare industry. According to ISPE, these enhancements are designed to celebrate its decade-long legacy and will include a new gala to recognize Category Winners at the annual ISPE-FDA CGMP Conference (part of ISPE’s newly created Pharmaceutical Quality Week) and an expanded presence for Category Winners at the ISPE Annual Meeting.

“Over the past decade,” Nancy Berg, ISPE President and CEO, explained, “the pharmaceutical and biopharmaceutical industry has made significant advancements in the technology and processes used in building and renovating manufacturing facilities. These advancements reflect the industry’s quest for excellence and superior product quality. As the premier awards program focused on recognizing these achievements, it is only fitting that the Facility of the Year Awards also make advancements in the way it showcases the Category Winners’ momentous accomplishments.”

The 2014 awards program is now accepting entries through February 3rd, 2014. Winners will be recognized in June in six categories: Operational Excellence, Project Execution, Equipment Innovation, Process Innovation, Sustainability, and Facility Integration. Companies interested in submitting their newly constructed or renovated facilities for the 2014 FOYA program can find complete eligibility criteria, program timelines and required entry forms at www.FacilityoftheYear.org/SubmitYourFacility.

Bayer has exercised its option, under a change-in-control clause in the collaboration agreement with Loxo Oncology, to obtain the exclusive licensing rights for the global development and commercialization of two cancer drugs.

A mix of feature articles and current new stories that are critical to staying up-to-date on the industry, delivered to your inbox. Choose from an assortment of different topics and frequencies. Subscribe Today.